48
CHAPTER 20 DNA TECHNOLOGY AND GENOMICS

CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

  • View
    219

  • Download
    2

Embed Size (px)

Citation preview

Page 1: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

CHAPTER 20DNA TECHNOLOGY AND

GENOMICS

Page 2: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 3: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

DIABETES Insufficient insulin (gene product) in the body

Insulin in the seeds of this Safflower plant

Insulin in themilk of this Argentinian cow!

Page 4: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

“Over hot pastrami and corned beef sandwiches, Herbert Boyer and Stanley Cohen opened the door to genetic engineering and laid the foundations for gene therapy and the biotechnology industry.”1996 Lemelson-MIT Prize Winners

Page 5: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

DNA technology – using DNA as a tool for advancement in research and medicine

o Biotechnology – using “life” to make useful products

• Recombinant DNA -genes from two different sources - are combined in vitro into the same molecule.

• Genetic engineering - the direct manipulation of genes for practical purposes.

Page 6: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Insulin-a hormone produced by pancreas--a protein---a gene product

-Diabetes Treatments:-Supply artificial insulin-Then insulin (a gene product) has to be manufactured (how?)-Gene therapy to fix defect

Page 7: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Goals of Bio/DNA technology1) Isolate insulin or ‘gene of interest’ from the human genome

2) Engineer a recombinant DNA (ex. chimeric plasmid) that has the ‘gene of interest’

3) Clone the recombinant DNA (ex: in bacteria) to make million of copies

4) Now the gene of interest can be excised out of the cloned bacteria colonies using probes that bind selectively to the gene of interest (now you have millions of copies of your gene)

5) You can introduce this gene into an egg/sperm/balstocyst (early embryo) of any organism, or culture it to make your human gene’s protein

Page 9: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Restriction Enzymes: found in bacteria naturally -used to cut foreign DNA in bacteria

• Most restrictions enzymes are very specific, recognize short DNA nucleotide sequences and cut at specific point in these sequences.– Bacteria protect their own

DNA by methylation.

Goal 1: Isolate gene of interest - ‘cut it’ out of human genomeGoal 2: Make recombinant DNA - ‘paste’ human gene in plasmid

Page 10: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Restriction Enzymes:• Cut at Restriction Sites

on DNA• Restriction sites are

often palindromes• Restriction enzymes

leave sticky ends on the DNA they cut

• Paste - seal with DNA ligase

• How can you use this information to make recombinant DNA?

Page 11: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Making Recombinant DNA

• Cut at SAME Restriction Sites on plasmid DNA and DONOR DNA (with gene of interest)

• Use DNA Ligase to join the sticky ends

Page 12: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Step 1: Bacterial transformation - gets recombinant plasmid DNA into bacteria (use heat shock + CaCl2 to drill holes so foreign DNA is accepted)

• Now the recombinant DNA can be “cloned” this means - make many, many copies of the DNA by growing the bacteria on agar plates

Goal 3: Clone the recombinant DNA - reinsert the plasmid (vector) back into bacteria and let bacteria grow

Vector - used to clone the recombinant DNA

Page 13: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 14: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Step 2a: How will you know if the bacterial clone has the recombinant DNA?

Plasmid Vector has: Antibiotic (amp+/tet+) resistance gene - grow the bacterial culture in antibiotics and select colony that has resistanceRestriction sitesOri Site -starts replicationMarker/reporter that can be used to identify recombinant event (Ex. luciferase+ glowing gene from FIREFLY DNA)

Luc+ Amp+

Ori

Page 15: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

LB = Only AgarNo Amp

LB + Amp LB+ Amp

No luc+ luc+No luc+

Amp Amp AmpLuc+

Negative Control Negative Control

Amp is an antibiotic; Amp+ is a gene on the plasmid that confers resistance. Luc+ makes bacteria glow.

Genes

Medium

AP Lab

Page 16: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Another Selection technique to pull out colony with gene of interest:Step 2b

-Nucleic acid hybridization depends on base pairing between DNA/RNA of interest and a complementary sequence, a nucleic acid probe

-A radioactive or fluorescent tag labels the probe.

- Bacterial colonies are transferred to a special filter paper (nitrocellulose)

- Colony containing the gene of interest can be identified using a probe that hybridizes (pairs) with the gene of interest

Page 17: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Can you take a human gene and insert it into a bacteria using a plasmid vector and expect it to make protein?

• AHEM! What about introns? (remember a gene has both the introns and exons!)

• Solution: Use the spliced mRNA. Use reverse transcriptase and synthesize a complementary strand.– This is complementary DNA (cDNA), – Attach cDNA to a vector for replication,

transcription, and translation inside bacteria.

2 problems in making recombinant DNA in eukaryotes:

1) How do you get the correct mRNA out of a human cell (to make the cDNA)

In other words – how can the correct RNA/DNA be recognized in a cell?

2) How do you open up a eukaryotic cell and make it take up foreign DNA?

Page 18: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Several techniques facilitate entry of foreign DNA in Eukaryotic Cells.– Electroporation- brief electrical pulses create a

temporary hole in the plasma membrane – Inject DNA into individual cells using microscopically thin

needles.– DNA is attached to microscopic metal particles and fired

into cells with a gun.

Page 19: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

So, can you store all the human genes in a recombinant form?

• Book = bacteria• Each Chapter =

Different Plasmid• What will the

human gene be?• Passages in

chapters = human gene of interest

• Genomic Library – stores all the genes of an organisms in a library of vectors

Page 20: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• cDNA library - mRNAs are converted to complimentary or cDNA and stored in the library

Page 21: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• “Shotgun” cloning - a mixture of fragments from the entire genome is included in thousands of different recombinant plasmids.

Cloned genes are stored in DNA libraries

Page 22: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 23: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Celera- Shotgun approach:

Chop up the entire genome into small fragments

Determine the sequence of each individual part and then overlap segments to find the order of 300 billion base pairs!

Diploid Human DNA sequence determined in 2007 was Craig Venter’s!

Human genome project 1990 approach:

Use existing linkage maps and break up chromosomes into overlapping parts; make clones of the DNA -assigned to scienitists all over the country

Determine the sequence of each individual part and find the order of 300 billion base pairs!

Page 24: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 25: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• In addition to plasmids, bacteriophages can be cloning vectors for making libraries.

Page 26: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• The polymerase chain reaction (PCR) can clone DNA without using a vector

• HOW????

• WHAT DOES THIS IMPLY?

Do you always need a plasmid/vector to clone DNA?

Page 27: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• PCR-Reagents• 1) Primers - 20

nucleotide long single stranded DNA sequences that can hybridize with the gene of interest DNA at its very end.

• 2) Free nucleotides• 3) Special DNA

polymerase called Taq Polymerase - from bacteria that live in hot springs

Fig. 20.7

• PCR-Steps• 1) Heat to 95c - denature DNA

to break up ds DNA in gene of interest

• 2) Lower the temp. to 60c - Primers can bind to the ends of gene of interest

• 3) Next increase temp to 75c for Taq Polymerase to work well - it adds free nucleotides to 3’ end of primers

• 4) One cycle - 2 strands, 2 cycles - 4 copies, 3 cycles - 8 copies, …. 25 cycle - 33 million copies!

-Amplify a small amount of DNA quickly!

Page 28: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Why PCR, when plasmids are available -

re-inventing the wheel, you say?• PCR can make billions of copies of a targeted

DNA segment in a few hours. • How can it do that?• PCR, is a three-step cycle: heating, cooling, and

replication• PCR, is like an atomic bomb explosion - HOW?• -a chain reaction that produces an exponentially

growing population of DNA molecules• Remember- PCR uses an UNUSUAL DNA

polymerase, isolated from bacteria living in hot springs, (can withstand the heat needed to separate the DNA strands at the start of each cycle).

Page 29: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 30: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Goal 4: Remove gene of interest from the cloned library using gel electrophoresis

• Comparison of 2 genomes: Gel Electrophoresis• DNA is –ve; Pass electric current• DNA will move to +ve electrode• So what?

Get DNA Fragments (use Restriction Enzyme digest)) Agarose

Gel

ParticlePores in gel thru which DNA fragments move

Know this! Rate of movement of DNA Fragment mainly depends on length or number of base pairs

Apply an electric current - DNA moves to +ve poleLong fragment

Short fragment

Page 31: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

DNA Gel electrophoresis• Can detect differences in DNA

fragment size/length• DNA fragments arise from

restriction enzymes that cut DNA into different sizes

• Depending on where the ‘cutting’ or restriction sites lie on the noncoding regions of the chromosome you get different DNA gel patterns - so every person has a unique restriction digest profile - RFLP (rif- lips) Restriction Fragment Length Polymorphism (many forms)

• You inherit these restriction sites according to Mendelian rules

DNA FINGERPRINTING

Page 32: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

DNA FINGERPRINTING USING RFLPS

Page 33: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Restriction fragment analysis is sensitive enough to distinguish between two alleles of a gene that differ by only base pair in a restriction site.

Fig. 20.9

Remember these differences are in the noncoding parts - but restriction sites may lie close to a gene and serve as a ‘marker’ for that gene

Page 34: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• For our three individuals, the results of these steps show that individual III has a different restriction pattern than individuals I or II.

Fig. 20.10

Summary: Restriction fragment length polymorphisms (RFLPs) – we each have a different site where the restriction enzymes cut - DNA fingerprinting maps this out on a gel

• RFLPs can serve as a genetic marker for diseases

Page 35: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Southern blotting

• Helps identify the gene of interest in the gel electrophoresis bands

• Uses probes to hybridize with the gel band copy on a nitrocellulose paper

• The band of interest can be cut out and the gene of interest can be isolated - now we have millions of coies of pure gene of interest.

Page 36: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 37: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Insert the gene of interest in an egg/sperm and create a

transgenic animal

• Microinject the gene of interest into the egg/sperm nucleus!

• Animal makes human protein!• Plant is totipotent - so no need to use

embryos - get it into leaf or stem or root of a plant and culture it - these cells can make a transgenic embryo!

Page 38: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin
Page 39: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

Microarrays: Attach all the dna/genes from an organism as single strands on a microarray plate. Ad cDNA from a patient .Spots where any of the cDNA hybridizes fluoresce with an intensity indicating the relative amount of the mRNA that was in the tissue.Gene chips

Page 40: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• In chromosome walking, the researcher starts with a known DNA segment (cloned, mapped, and sequenced) and “walks” along the DNA from that locus, producing a map of overlapping fragments.

Fig. 20.11

Page 41: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Genomics, the study of genomes based on their DNA sequences, is yielding new insights into fundamental questions about genome organization, the control of gene expression, growth and development, and evolution.

• Rather than inferring genotype from phenotype like classical geneticists, molecular geneticists try to determine the impact on the phenotype of details of the genotype.

Genome sequences provide clues to important biological questions

• By doing more mixing and matching of modular elements, humans - and vertebrates in general - reach more complexity than flies or worms.

– The typical human gene probably specifies at least two or three different polypeptides by using different combinations of exons.

• Along with this is additional polypeptide diversity via post-translational processing.

– The human sequence suggests that our polypeptides tend to be more complicated than those of invertebrates.

• While humans do not seem to have more types of domains, the domains are put together in many more combinations.

Page 42: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• About half of the human genes were already known before the Human Genome Project.

• To determine what the others are and what they may do, scientists compare the sequences of new gene candidates with those of known genes.– In some cases, the sequence of a new gene candidate will be similar in

part with that of known gene, suggesting similar function.– In other cases, the new sequences will be similar to a sequence

encountered before, but of unknown function.– In still other cases, the sequence is entirely unlike anything ever seen

before.• About 30% of the E. coli genes are new to us.

Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings

• Comparisons of genome sequences confirm very strongly the evolutionary connections between even distantly related organisms and the relevance of research on simpler organisms to our understanding of human biology.

– For example, yeast has a number of genes close enough to the human versions that they can substitute for them in a human cell.

– Researchers may determine what a human disease gene does by studying its normal counterpart in yeast.

– Bacterial sequences reveal unsuspected metabolic pathways that may have industrial or medical uses.

Page 43: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Studies of genomes have also revealed how genes act together to produce a functioning organism through an unusually complex network of interactions among genes and their products.

• To determine which genes are transcribed under different situations, researchers isolate mRNA from particular cells and use the mRNA as templates to build a cDNA library.

• This cDNA can be compared to other collections of DNA by hybridization.– This will reveal which genes are active at different

developmental stages, in different tissues, or in tissues in different states of health.

Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings

Page 44: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Perhaps the most interesting genes discovered in genome sequencing and expression studies are those whose function is completely mysterious.

• One way to determine their function is to disable the gene and hope that the consequences provide clues to the gene’s normal function.– Using in vitro mutagenesis, specific changes

are introduced into a cloned gene, altering or destroying its function.

– When the mutated gene is returned to the cell, it may be possible to determine the function of the normal gene by examining the phenotype of the mutant.Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings

Page 45: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• In nonmammalian organisms, a simpler and faster method, RNA interference (RNAi), has been applied to silence the expression of selected genes.– This method uses synthetic double-stranded

RNA molecules matching the sequences of a particular gene to trigger breakdown of the gene’s mRNA.

– The mechanism underlying RNAi is still unknown.

– Scientists have only recently achieved some success in using the method to silence genes in mammalian cells.

Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings

Page 46: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• The next step after mapping and sequencing genomes is proteomics, the systematic study of full protein sets (proteomes) encoded by genomes.– One challenge is the sheer number of proteins in

humans and our close relatives because of alternative RNA splicing and post-translational modifications.

– Collecting all the proteins will be difficult because a cell’s proteins differ with cell type and its state.

– In addition, unlike DNA, proteins are extremely varied in structure and chemical and physical properties.

– Because proteins are the molecules that actually carry out cell activities, we must study them to learn how cells and organisms function.

Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings

Page 47: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• Genomic and proteomics are giving biologists an increasingly global perspective on the study of life.

• Eric Lander and Robert Weinberg predict that complete catalogs of genes and proteins will change the discipline of biology dramatically.– “For the first time in a century, reductionists [are yielding]

ground to those trying to gain a holistic view of cells and tissues.”

• Advances in bioinformatics, the application of computer science and mathematics to genetic and other biological information, will play a crucial role in dealing with the enormous mass of data.

Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings

Page 48: CHAPTER 20 DNA TECHNOLOGY AND GENOMICS. DIABETES Insufficient insulin (gene product) in the body Insulin in the seeds of this Safflower plant Insulin

• These analyses will provide understanding of the spectrum of genetic variation in humans.– Because we are all probably descended from a small

population living in Africa 150,000 to 200,000 years ago, the amount of DNA variation in humans is small.

– Most of our diversity is in the form of single nucleotide polymorphisms (SNPs), single base-pair variations.• In humans, SNPs occur about once in 1,000 bases, meaning

that any two humans are 99.9% identical.

– The locations of the human SNP sites will provide useful markers for studying human evolution and for identifying disease genes and genes that influence our susceptibility to diseases, toxins or drugs.

Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings